@article {WEIDLE132, author = {ULRICH H. WEIDLE and ADAM NOPORA}, title = {Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets}, volume = {20}, number = {2}, pages = {132--153}, year = {2023}, doi = {10.21873/cgp.20369}, publisher = {International Institute of Anticancer Research}, abstract = {Patients with disseminated colorectal cancer have a dismal prognosis with a 5-year survival rate of only 13\%. In order to identify new treatment modalities and new targets, we searched the literature for up-regulated circular RNAs in colorectal cancer which induce tumor growth in corresponding preclinical in vivo models. We identified nine circular RNAs that mediate resistance against chemotherapeutic agents, seven that up-regulate transmembrane receptors, five that induce secreted factors, nine that activate signaling components, five which up-regulate enzymes, six which activate actin-related proteins, six which induce transcription factors and two which up-regulate the MUSASHI family of RNA binding proteins. All of the circular RNAs discussed in this paper induce the corresponding targets by sponging microRNAs (miRs) and can be inhibited by RNAi or shRNA in vitro and in xenograft models. We have focused on circular RNAs with demonstrated activity in preclinical in vivo models because the latter is an important milestone in drug development. All circular RNAs with in vitro activity only data are not referenced in this review. The translational impact of inhibition of these circular RNAs and of the identified targets for treatment of colorectal cancer (CRC) are discussed.}, issn = {1109-6535}, URL = {https://cgp.iiarjournals.org/content/20/2/132}, eprint = {https://cgp.iiarjournals.org/content/20/2/132.full.pdf}, journal = {Cancer Genomics \& Proteomics} }